Report overview
Drug delivery system introduces therapeutic substance in the body as formulation or device to improve its efficiency and safety. There was requirement drug delivery system that could maintain the steady release of therapeutic drugs within the specific site. Implantable drug delivery system becomes new kind of drug delivery system which can directly implant in the human body to optimize therapeutic properties. This system is more steady, effective, safe and reliable than other drug delivery system. For intravenous drug delivery system, drugs actions were short, and frequent injections were required. For topical drug delivery system, absorption drug may be limited due physiochemical characteristic of drugs. Implantable drug delivery system does not have limitation associated with intravenous and topical drug delivery system beside it is controlled drug delivery system.
This report contains market size and forecasts of Implantable Drug Delivery Systems in Global, including the following market information:
Global Implantable Drug Delivery Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Implantable Drug Delivery Systems market was valued at 482 million in 2021 and is projected to reach US$ 672.8 million by 2028, at a CAGR of 4.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Biodegradable Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Implantable Drug Delivery Systems include Boston Scientific Corporation, Bayer Healthcare, Medtronic Inc., Allergan Inc., Abbott laboratories, Bausch and Lomb Inc., Genetech Inc., PSivda Corporation and Medtronic, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Implantable Drug Delivery Systems companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Implantable Drug Delivery Systems Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Implantable Drug Delivery Systems Market Segment Percentages, by Type, 2021 (%)
Biodegradable
Non-Biodegradable
Global Implantable Drug Delivery Systems Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Implantable Drug Delivery Systems Market Segment Percentages, by Application, 2021 (%)
Diabetic Retinopathy
Cardiovascular Diseases
Colorectal Cancer
Osteoporosis
Ocular Diseases
Brain Tumors
Other
Global Implantable Drug Delivery Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Implantable Drug Delivery Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Implantable Drug Delivery Systems revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Implantable Drug Delivery Systems revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boston Scientific Corporation
Bayer Healthcare
Medtronic Inc.
Allergan Inc.
Abbott laboratories
Bausch and Lomb Inc.
Genetech Inc.
PSivda Corporation
Medtronic
Varian Medical System
Arrow International
Neurotech Pharmaceuticals
Replenish Inc.
